These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14720204)

  • 1. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells.
    Biasini E; Fioriti L; Ceglia I; Invernizzi R; Bertoli A; Chiesa R; Forloni G
    J Neurochem; 2004 Feb; 88(3):545-53. PubMed ID: 14720204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
    Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
    Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
    Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
    Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
    Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
    J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin accumulation in aggresomes due to proteasome impairment.
    Junn E; Lee SS; Suhr UT; Mouradian MM
    J Biol Chem; 2002 Dec; 277(49):47870-7. PubMed ID: 12364339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways of neurodegeneration in Parkinson's disease.
    Dawson TM; Dawson VL
    Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Ancolio K; Alves da Costa C; Uéda K; Checler F
    Neurosci Lett; 2000 May; 285(2):79-82. PubMed ID: 10793231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
    Tofaris GK; Layfield R; Spillantini MG
    FEBS Lett; 2001 Nov; 509(1):22-6. PubMed ID: 11734199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation.
    Li W; Lesuisse C; Xu Y; Troncoso JC; Price DL; Lee MK
    J Neurosci; 2004 Aug; 24(33):7400-9. PubMed ID: 15317865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
    Rideout HJ; Larsen KE; Sulzer D; Stefanis L
    J Neurochem; 2001 Aug; 78(4):899-908. PubMed ID: 11520910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
    Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
    J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.
    Stefanis L; Larsen KE; Rideout HJ; Sulzer D; Greene LA
    J Neurosci; 2001 Dec; 21(24):9549-60. PubMed ID: 11739566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines.
    Martìn-Clemente B; Alvarez-Castelao B; Mayo I; Sierra AB; Dìaz V; Milán M; Fariñas I; Gómez-Isla T; Ferrer I; Castaño JG
    J Biol Chem; 2004 Dec; 279(51):52984-90. PubMed ID: 15466467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.